NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Autoři
STUPP, Roger; Eric T WONG; Andrew A KANNER; David STEINBERG; Herbert ENGELHARD; Volkmar HEIDECKE; Eilon D KIRSON; Sophie TAILLIBERT; Frank LIEBERMANN; Vladimír DBALÝ; Zvi RAM; J Lee VILLANO; Nikolai RAINOV; Uri WEINBERG; David SCHIFF; Lara KUNSCHNER; Jeffrey RAIZER; Jerome HONNORAT; Andrew SLOAN; Mark MALKIN; Joseph C LANDOLFI; Franz PAYER; Maximilian MEHDORN; Robert J WEIL; Susan C PANNULLO; Manfred WESTPHAL; Martin SMRČKA; Lawrence CHIN; Herwig KOSTRON; Silvia HOFER; Jeffrey BRUCE; Rees COSGROVE; Nina PALEOLOGOUS; Yoram PALTI a Philip H GUTIN
Vydání
European Journal of Cancer, Oxford, UK, ELSEVIER, 2012, 0959-8049
NovoTTF-100A is a portable device delivering low-intensity, intermediate frequency electric fields via non-invasive, transducer arrays. Tumour Treatment Fields (TTF), a completely new therapeutic modality in cancer treatment, physically interfere with cell division.
STUPP, Roger; Eric T WONG; Andrew A KANNER; David STEINBERG; Herbert ENGELHARD; Volkmar HEIDECKE; Eilon D KIRSON; Sophie TAILLIBERT; Frank LIEBERMANN; Vladimír DBALÝ; Zvi RAM; J Lee VILLANO; Nikolai RAINOV; Uri WEINBERG; David SCHIFF; Lara KUNSCHNER; Jeffrey RAIZER; Jerome HONNORAT; Andrew SLOAN; Mark MALKIN; Joseph C LANDOLFI; Franz PAYER; Maximilian MEHDORN; Robert J WEIL; Susan C PANNULLO; Manfred WESTPHAL; Martin SMRČKA; Lawrence CHIN; Herwig KOSTRON; Silvia HOFER; Jeffrey BRUCE; Rees COSGROVE; Nina PALEOLOGOUS; Yoram PALTI a Philip H GUTIN. NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality. European Journal of Cancer. Oxford, UK: ELSEVIER, 2012, roč. 48, č. 14, s. 2192-2202. ISSN 0959-8049. Dostupné z: https://doi.org/10.1016/j.ejca.2012.04.011.
@article{1082946, author = {Stupp, Roger and Wong, Eric T and Kanner, Andrew A and Steinberg, David and Engelhard, Herbert and Heidecke, Volkmar and Kirson, Eilon D and Taillibert, Sophie and Liebermann, Frank and Dbalý, Vladimír and Ram, Zvi and Villano, J Lee and Rainov, Nikolai and Weinberg, Uri and Schiff, David and Kunschner, Lara and Raizer, Jeffrey and Honnorat, Jerome and Sloan, Andrew and Malkin, Mark and Landolfi, Joseph C and Payer, Franz and Mehdorn, Maximilian and Weil, Robert J and Pannullo, Susan C and Westphal, Manfred and Smrčka, Martin and Chin, Lawrence and Kostron, Herwig and Hofer, Silvia and Bruce, Jeffrey and Cosgrove, Rees and Paleologous, Nina and Palti, Yoram and Gutin, Philip H}, article_location = {Oxford, UK}, article_number = {14}, doi = {https://doi.org/10.1016/j.ejca.2012.04.011}, keywords = {Glioblastoma - Brain tumour - Chemotherapy - Randomised trial}, language = {eng}, issn = {0959-8049}, journal = {European Journal of Cancer}, title = {NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality}, volume = {48}, year = {2012} }
TY - JOUR ID - 1082946 AU - Stupp, Roger - Wong, Eric T - Kanner, Andrew A - Steinberg, David - Engelhard, Herbert - Heidecke, Volkmar - Kirson, Eilon D - Taillibert, Sophie - Liebermann, Frank - Dbalý, Vladimír - Ram, Zvi - Villano, J Lee - Rainov, Nikolai - Weinberg, Uri - Schiff, David - Kunschner, Lara - Raizer, Jeffrey - Honnorat, Jerome - Sloan, Andrew - Malkin, Mark - Landolfi, Joseph C - Payer, Franz - Mehdorn, Maximilian - Weil, Robert J - Pannullo, Susan C - Westphal, Manfred - Smrčka, Martin - Chin, Lawrence - Kostron, Herwig - Hofer, Silvia - Bruce, Jeffrey - Cosgrove, Rees - Paleologous, Nina - Palti, Yoram - Gutin, Philip H PY - 2012 TI - NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality JF - European Journal of Cancer VL - 48 IS - 14 SP - 2192-2202 EP - 2192-2202 PB - ELSEVIER SN - 09598049 KW - Glioblastoma - Brain tumour - Chemotherapy - Randomised trial N2 - NovoTTF-100A is a portable device delivering low-intensity, intermediate frequency electric fields via non-invasive, transducer arrays. Tumour Treatment Fields (TTF), a completely new therapeutic modality in cancer treatment, physically interfere with cell division. ER -
STUPP, Roger; Eric T WONG; Andrew A KANNER; David STEINBERG; Herbert ENGELHARD; Volkmar HEIDECKE; Eilon D KIRSON; Sophie TAILLIBERT; Frank LIEBERMANN; Vladimír DBALÝ; Zvi RAM; J Lee VILLANO; Nikolai RAINOV; Uri WEINBERG; David SCHIFF; Lara KUNSCHNER; Jeffrey RAIZER; Jerome HONNORAT; Andrew SLOAN; Mark MALKIN; Joseph C LANDOLFI; Franz PAYER; Maximilian MEHDORN; Robert J WEIL; Susan C PANNULLO; Manfred WESTPHAL; Martin SMRČKA; Lawrence CHIN; Herwig KOSTRON; Silvia HOFER; Jeffrey BRUCE; Rees COSGROVE; Nina PALEOLOGOUS; Yoram PALTI a Philip H GUTIN. NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality. \textit{European Journal of Cancer}. Oxford, UK: ELSEVIER, 2012, roč.~48, č.~14, s.~2192-2202. ISSN~0959-8049. Dostupné z: https://doi.org/10.1016/j.ejca.2012.04.011.